These results are in agreement with findings in other transgenic models of AD in which transgenic mice having mutant forms of APP or presenilin-1 demonstrated impaired neurogenesis [20]–[22], [24], [27], [28]. The gene discussed is PSEN1; the disease is Alzheimer disease.